US 8476254
Methods for treating psychosis associated with interferson-α therapy
granted A61KA61K31/56A61K31/573
Quick answer
US patent 8476254 (Methods for treating psychosis associated with interferson-α therapy) held by Corcept Therapeutics Incorporated expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/56, A61K31/573, A61K31/58, A61K31/7056